![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 04, 2014 5:15:48 PM
Address of the issuer’s principal executive offices
Company Headquarters
Address 1: PO Box 107
Address 2: Milford
Address 3: PA 18337
Phone: 570-249-6000
Email: info@manzopharma.com Website(s): www.manzopharma.com
IR Contact
Address 1: PO Box 107
Address 2: Milford
Address 3: PA 18337
Phone: 570-249-6000
Email: info@manzopharma.com Website(s): www.manzopharma.com
For the people that refuse to believe the obvious...
http://ihaveabridgetosellyou.com
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM